Atectura Breezhaler

indacaterol acetate; mometasone furoate · Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atectura Breezhaler, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: EMA Authorised: Atectura Breezhaler (indacaterol acetate;mometasone furoate) — Novartis Europharm Limited